Guido C. Paesen

Centre for Human Genetics — United Kingdom

Neuroscience · Life Sciences

27h-index5.6kcitations80works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurobiology and Insect Physiology Research(15), Vector-borne infectious diseases(12), Virus-based gene therapy research(10), Insect and Pesticide Research(10), Viral Infections and Vectors(10)

Publications80 total

Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain
PLoS Pathogens·2026Open Access
Conserved dimerization architecture in C-type lectins from virus-vector mosquitoes
2026
Author response: Structure-guided loop grafting improves expression and stability of influenza neuraminidase for vaccine development
2025Open Access
Structure-guided loop grafting improves expression and stability of influenza neuraminidase for vaccine development
eLife·2025· 1 citedOpen Access
Structure and stabilization of the antigenic glycoprotein building blocks of the New World mammarenavirus spike complex
mBio·2025· 2 citedOpen Access
Author response: Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
2025Open Access
Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
2025Open Access
Structure-guided loop grafting improves expression and stability of influenza neuraminidase for vaccine development
eLife·2025· 1 citedOpen Access
Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
2025Open Access
Author response: Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
2025Open Access
Structure-Guided Loop Grafting Improves Expression and Stability of Influenza Neuraminidase for Vaccine Development
2024Open Access
Structure and stabilization of the antigenic glycoprotein building blocks of the New World mammarenavirus spike complex
2024· 1 citedOpen Access
Central tolerance shapes the neutralizing B cell repertoire against a persisting virus in its natural host
Proceedings of the National Academy of Sciences·2024· 10 citedOpen Access
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
Nature Communications·2023· 15 citedOpen Access
VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display
mSphere·2023· 4 citedOpen Access
VelcroVax: a ‘bolt-on’ vaccine platform technology improves antibody titres against a viral glycoprotein in mice
2022Open Access
Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies
mBio·2022· 18 citedOpen Access
Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2
2021· 40 cited
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Cell·2021· 1.1k citedOpen Access
Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure
Viruses·2021· 79 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Adriana Patrícia(14), David I. Stuart(10), Jonathan M. Grimes(8), Paul Klenerman(8), Alexander J. Mentzer(7), Tao Dong(7), Thomas A. Bowden(7), Arnold De Loof(7), Piyada Supasa(6), Chang Liu(6), César López‐Camacho(6), Jose Slon-Campos(6), Yuguang Zhao(6), Beibei Wang(6), Christina Dold(6), Robert H. Levin(6), Gavin Screaton(6), Julian C. Knight(6), Miles A. Nunn(6), Wanwisa Dejnirattisai(5)